Twist Bioscience Corporation (NASDAQ: TWST) reported Q1 EPS of ($0.50), $0.07 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $103.7 million versus the consensus estimate of $100.72 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.